NCT07392125Phase 3Not yet recruiting

Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes

Study sponsor: Achieve Life Sciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11-15Estimated
Enrollment · participants800Estimated
Source updated2026-02-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.